# COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur

> **NCT04369066** · NA · COMPLETED · sponsor: **Institut Curie** · enrollment: 1971 (actual)

## Conditions studied

- Volunteers From the Institute Curie and Institute Pasteur Staff Who Are Not Showing Active SARS-CoV-2 Infection

## Interventions

- **DIAGNOSTIC_TEST:** Blood samples (collection of 5 mL of blood in a dry tube)
- **DIAGNOSTIC_TEST:** Nasopharyngeal swabs

## Key facts

- **NCT ID:** NCT04369066
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-28
- **Primary completion:** 2022-01-06
- **Final completion:** 2022-05-13
- **Target enrollment:** 1971 (ACTUAL)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04369066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04369066, "COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04369066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*